These medicines are administered by subcutaneous injection, with formulations available for twice-daily, once-daily, or once-weekly dosing depending on the specific agent
OR = 2.40 [1.623.56])with an even greater difference in the proportion using them exclusively for weight loss (2.8% [70.0% of female users] vs
For adults who have struggled with appetite, cravings, insulin resistance, or weight that returns after dieting, GLP-1 treatment may be worth discussing with a qualified clinician
The treatment comparison reveals GHK-Cu discontinuation profile proving more favorable than retinoids (less dependency, no rebound, better benefit retention) while similar to vitamin C and niacinamide (gradual decline, moderate long-term retention, low dependency)